אופטילסט ישראל - עברית - Ministry of Health

אופטילסט

megapharm ltd - azelastine hydrochloride - טיפות עיניים - azelastine hydrochloride 0.05 % - azelastine - azelastine - symptomatic treatment and prevention of seasonal allergic conjunctivitis.

אגיוקור ישראל - עברית - Ministry of Health

אגיוקור

megapharm ltd - ispaghula husks; ispaghula seed - גרנולות - ispaghula husks 2.2 g / 100 g; ispaghula seed 65 g / 100 g - bulk producers - managemant of bowel function.

אמנדין  100 ישראל - עברית - Ministry of Health

אמנדין 100

megapharm ltd - amantadine hemisulfate - טבליות מצופות פילם - amantadine hemisulfate 100 mg - amantadine

אמנדין 100 ישראל - עברית - Ministry of Health

אמנדין 100

megapharm ltd - amantadine hemisulfate - טבליות מצופות פילם - amantadine hemisulfate 100 mg - amantadine

סילריל 2.5 ישראל - עברית - Ministry of Health

סילריל 2.5

unipharm ltd, israel - cilazapril - טבליה - cilazapril 2.5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.

סילריל 5 ישראל - עברית - Ministry of Health

סילריל 5

unipharm ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.

סילריל פלוס ישראל - עברית - Ministry of Health

סילריל פלוס

unipharm ltd, israel - cilazapril; hydrochlorothiazide - טבליה - cilazapril 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

סילריל 1 ישראל - עברית - Ministry of Health

סילריל 1

unipharm ltd, israel - cilazapril - טבליה - cilazapril 1 mg - cilazapril - cilazapril - a blood pressure lowering agent.chronic heart failure.

טורבה 10 ישראל - עברית - Ministry of Health

טורבה 10

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 10 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

טורבה 20 ישראל - עברית - Ministry of Health

טורבה 20

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 20 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/